These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6888072)

  • 1. [Viral hepatitis and drug-addiction].
    Med Clin (Barc); 1983 Jun; 81(3):136-7. PubMed ID: 6888072
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatic lesions in drug addiction].
    Dal Monte PR; D'Imperio N; Formica G; Giuliani-Piccari G; Marzot G; Milandri G; Piemontese A; Ruggieri M; Sarti F; Spongano P
    G Clin Med; 1981 Feb; 62(2):83-92. PubMed ID: 7239058
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of a treatment with a thymus extract (thymostimulin) in acute viral hepatitis B in drug-dependent patients].
    Corridori S; Trespi G; Baldini E; Renzetti I; Calderon W
    Boll Ist Sieroter Milan; 1984; 63(6):519-28. PubMed ID: 6242017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of epidemic delta infection in drug addicts.
    Caredda F; d'Arminio Monforte A; Rossi E; Farci P; Smedile A; Tappero G; Moroni M
    Prog Clin Biol Res; 1983; 143():245-50. PubMed ID: 6669581
    [No Abstract]   [Full Text] [Related]  

  • 5. What you need to know: interpreting hepatitis B viral markers.
    Tan CK
    Singapore Med J; 1998 Mar; 39(3):139-40. PubMed ID: 9632977
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
    Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral hepatitis among prisoners in Norway.
    Hurlen B; Siebke JC; Stensland A
    NIPH Ann; 1980 Dec; 3(2):129-32. PubMed ID: 7219839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Infectivity of hepatitis B].
    Gerken G
    Dtsch Med Wochenschr; 1996 Apr; 121(14):459. PubMed ID: 8665822
    [No Abstract]   [Full Text] [Related]  

  • 9. [Explanation of hepatitis B virus markers after hepatitis B vaccines inoculation].
    Chen H; Zhu QR
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):240. PubMed ID: 12716528
    [No Abstract]   [Full Text] [Related]  

  • 10. [Radioimmunoassay of E antigen and anti-E antibody system of hepatitis B virus].
    Novak I; Kselikova M; Urbankova I
    Probl Gematol Pereliv Krovi; 1982 Mar; 27(3):55-7. PubMed ID: 7088919
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis B immune globulin dose requirements following orthotopic liver transplantation for chronic hepatitis B cirrhosis.
    McGory R; Ishitani M; Oliveira W; Stevenson W; McCullough C; Pruett T
    Transplant Proc; 1996 Jun; 28(3):1687-8. PubMed ID: 8658840
    [No Abstract]   [Full Text] [Related]  

  • 12. The prevalence of hepatitis B surface antigen (HBsAg) among drug-dependent patients in Jeddah, Saudi Arabia.
    Njoh J
    East Afr Med J; 1995 Mar; 72(3):198-9. PubMed ID: 7796776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between HBeAg/anti-HBe and other hepatitis B virus (HBV) markers in healthy carriers.
    Musca A; Cordova C; Barnaba V; Zaccari C
    Quad Sclavo Diagn; 1981 Sep; 17(3):363-9. PubMed ID: 7343989
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progresses in the molecular diagnosis of hepatitis B viral infection].
    Panait M; Oprişan G; Codiţă I
    Bacteriol Virusol Parazitol Epidemiol; 2008; 53(1):5-12. PubMed ID: 19241991
    [No Abstract]   [Full Text] [Related]  

  • 15. Viral load in hepatitis B e antigen-negative carriers with normal aminotransferase level.
    Liaw YF
    Hepatology; 2007 Sep; 46(3):947; author reply 947-9. PubMed ID: 17705263
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific considerations in the design of hepatitis B virus clinical studies in the far East.
    Yuen MF; Lai CL
    Methods Mol Med; 2004; 96():457-64. PubMed ID: 14762287
    [No Abstract]   [Full Text] [Related]  

  • 17. High dose lamivudine and hepatitis B.
    Musher DR; Wasser WG; Saggi SJ
    Am J Gastroenterol; 1999 Nov; 94(11):3372. PubMed ID: 10566751
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis].
    Marinucci G; Muglia M; Di Giacomo C; Petrucci L; Mancini R; Costa F; Bachetoni A
    Quad Sclavo Diagn; 1981 Mar; 17(1):81-5. PubMed ID: 7313073
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dynamics of HBV-DNA level in acute hepatitis B].
    Zhao H; Cao JH; Tian GS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):159-61. PubMed ID: 12870000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.